Draegerwerk AG & Co KGaA
XETRA:DRW8
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
40.1
47.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Draegerwerk AG & Co KGaA
Draegerwerk AG & Co KGaA
Research & Development
Draegerwerk AG & Co KGaA
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
Research & Development
-€328.1m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
Research & Development
-€352.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-14%
|
|
|
Stratec SE
XETRA:SBS
|
Research & Development
-€10.3m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-3%
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Siemens Healthineers AG
XETRA:SHL
|
Research & Development
-€1.9B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Sartorius AG
XETRA:SRT
|
Research & Development
-€185.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-15%
|
|
Draegerwerk AG & Co KGaA
Glance View
Draegerwerk AG & Co KGaA is a DE-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Luebeck, Schleswig-Holstein and currently employs 15,900 full-time employees. Draegerwerk AG & Co KGaA is a Germany-based provider of medical and safety technology. The firm operates through two segments: Medical and Safety. The Medical segment develops, produces and markets system solutions, equipment and services for the optimization of processes at the acute point of care, such as emergency care, preoperative care, critical care and prenatal care. The Safety segment develops, produces and markets products, system solutions and services for personal protection, gas detection technology and integrated hazard management for customers from various industries, such as mining, fire departments, police and disaster protection. The firm has production sites in Europe, the Americas, Africa and Asia.
See Also
What is Draegerwerk AG & Co KGaA's Research & Development?
Research & Development
-328.1m
EUR
Based on the financial report for Sep 30, 2024, Draegerwerk AG & Co KGaA's Research & Development amounts to -328.1m EUR.
What is Draegerwerk AG & Co KGaA's Research & Development growth rate?
Research & Development CAGR 10Y
-5%
Over the last year, the Research & Development growth was 3%. The average annual Research & Development growth rates for Draegerwerk AG & Co KGaA have been -11% over the past three years , -5% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
